Heath and Disease are Triggered by the Human Immune System.
Thus molecular understanding of basic homeostatic mechanisms in immunology, biochemistry and physiology is essential
for the development of innovative drug development and disease preventing or detecting technologies.
Novel biomedical technologies such as emerging proteomics support molecular networks analysis, biomarker development,
diagnostics and hypothesis & experimental driven drug targeting in translational and personalized medicine.
Applying cutting edge, next-generation medical biotechnologies, such as qualitative and quantitative mass spectrometry,
including bioinformatics and systems biology combined with preclinical expert knowledge and interdisciplinary skills will
allow us to develop iteratively new concepts, new assays and therapeutic strategies further.
Copyright & Contact:
Institute for Immunoproteomics